Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vector-Borne Transmission of Infection”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Not applicableStudy completedNCT00347113
What this trial is testing

Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania

Who this might be right for
AnaemiaMalariaHepatosplenomegaly
DBL -Institute for Health Research and Development 620
Early research (Phase 1)Looking for participantsNCT06607003
What this trial is testing

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Looking for participantsNCT04648046
What this trial is testing

CAR-T Cells for HIV Infection

Who this might be right for
HIV Infections
Steven Deeks 18
Not applicableUnknownNCT04084379
What this trial is testing

Implementation Strategy of Bio-molecular Techniques for Early Diagnose of Congenital Syphilis and Chagas Diseases

Who this might be right for
Chagas DiseaseSyphilis
Hospital de Niños R. Gutierrez de Buenos Aires 560
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Post-approval studies (Phase 4)Looking for participantsNCT06068530
What this trial is testing

Mass Vaccine and Drug Administration, Bangladesh

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 10,000
Early research (Phase 1)Study completedNCT00295581
What this trial is testing

PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria

Who this might be right for
Plasmodium FalciparumPlasmodium Vivax Malaria
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT03503058
What this trial is testing

Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria

Who this might be right for
Malaria
Sanaria Inc. 345
Testing effectiveness (Phase 2)WithdrawnNCT00415649
What this trial is testing

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Not Yet RecruitingNCT06881732
What this trial is testing

Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite With the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAP

Who this might be right for
Malaria FalciparumMalaria InfectionMalaria Transmission
University of Melbourne 2
Early research (Phase 1)Study completedNCT00119873
What this trial is testing

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Ended earlyNCT00865566
What this trial is testing

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Testing effectiveness (Phase 2)Study completedNCT00080106
What this trial is testing

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Not applicableStudy completedNCT00713999
What this trial is testing

Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar

Who this might be right for
Sexually Transmitted InfectionsSchistosoma Haematobium
University of Aarhus 680
Large-scale testing (Phase 3)Study completedNCT02610400
What this trial is testing

Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia

Who this might be right for
Malaria
University of California, San Francisco 9,845
Large-scale testing (Phase 3)Study completedNCT03671109
What this trial is testing

Improving Maternal heAlth by Reducing Malaria in African HIV Women

Who this might be right for
MalariaHIV/AIDSPregnancy Related
Barcelona Institute for Global Health 666
Testing effectiveness (Phase 2)Study completedNCT06413108
What this trial is testing

Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali

Who this might be right for
Malaria,Falciparum
Radboud University Medical Center 167
Not applicableStudy completedNCT01109342
What this trial is testing

Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00000884
What this trial is testing

Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 84
Next Page